vs

Side-by-side financial comparison of PAMT CORP (PAMT) and Tilray Brands, Inc. (TLRY). Click either name above to swap in a different company.

Tilray Brands, Inc. is the larger business by last-quarter revenue ($217.5M vs $141.3M, roughly 1.5× PAMT CORP). Tilray Brands, Inc. runs the higher net margin — -20.7% vs -20.7%, a 0.0% gap on every dollar of revenue. On growth, Tilray Brands, Inc. posted the faster year-over-year revenue change (3.1% vs -15.1%). Over the past eight quarters, Tilray Brands, Inc.'s revenue compounded faster (7.5% CAGR vs -12.0%).

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

PAMT vs TLRY — Head-to-Head

Bigger by revenue
TLRY
TLRY
1.5× larger
TLRY
$217.5M
$141.3M
PAMT
Growing faster (revenue YoY)
TLRY
TLRY
+18.2% gap
TLRY
3.1%
-15.1%
PAMT
Higher net margin
TLRY
TLRY
0.0% more per $
TLRY
-20.7%
-20.7%
PAMT
Faster 2-yr revenue CAGR
TLRY
TLRY
Annualised
TLRY
7.5%
-12.0%
PAMT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
PAMT
PAMT
TLRY
TLRY
Revenue
$141.3M
$217.5M
Net Profit
$-29.3M
$-44.9M
Gross Margin
26.4%
Operating Margin
-27.0%
-10.2%
Net Margin
-20.7%
-20.7%
Revenue YoY
-15.1%
3.1%
Net Profit YoY
7.4%
47.4%
EPS (diluted)
$-1.38
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PAMT
PAMT
TLRY
TLRY
Q4 25
$141.3M
$217.5M
Q3 25
$150.3M
$209.5M
Q2 25
$151.1M
$224.5M
Q1 25
$155.3M
$185.8M
Q4 24
$166.5M
$210.9M
Q3 24
$182.6M
$200.0M
Q2 24
$182.9M
$229.9M
Q1 24
$182.6M
$188.3M
Net Profit
PAMT
PAMT
TLRY
TLRY
Q4 25
$-29.3M
$-44.9M
Q3 25
$-5.6M
$-322.0K
Q2 25
$-9.6M
$-1.3B
Q1 25
$-8.1M
$-789.4M
Q4 24
$-31.6M
$-85.3M
Q3 24
$2.4M
$-39.2M
Q2 24
$-2.9M
$-31.7M
Q1 24
$281.0K
$-92.7M
Gross Margin
PAMT
PAMT
TLRY
TLRY
Q4 25
26.4%
Q3 25
27.4%
Q2 25
30.1%
Q1 25
28.0%
Q4 24
29.0%
Q3 24
29.8%
Q2 24
35.8%
Q1 24
26.2%
Operating Margin
PAMT
PAMT
TLRY
TLRY
Q4 25
-27.0%
-10.2%
Q3 25
-3.8%
1.0%
Q2 25
-7.3%
-643.1%
Q1 25
-5.9%
-409.0%
Q4 24
-22.6%
-20.0%
Q3 24
1.3%
-18.3%
Q2 24
-0.4%
-7.2%
Q1 24
-0.4%
-43.6%
Net Margin
PAMT
PAMT
TLRY
TLRY
Q4 25
-20.7%
-20.7%
Q3 25
-3.7%
-0.2%
Q2 25
-6.4%
-566.9%
Q1 25
-5.2%
-424.9%
Q4 24
-19.0%
-40.5%
Q3 24
1.3%
-19.6%
Q2 24
-1.6%
-13.8%
Q1 24
0.2%
-49.2%
EPS (diluted)
PAMT
PAMT
TLRY
TLRY
Q4 25
$-1.38
$-0.41
Q3 25
$-0.27
$0.00
Q2 25
$-0.46
$7.26
Q1 25
$-0.37
$-8.69
Q4 24
$-1.44
$-0.99
Q3 24
$0.11
$-0.04
Q2 24
$-0.13
$-0.04
Q1 24
$0.01
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PAMT
PAMT
TLRY
TLRY
Cash + ST InvestmentsLiquidity on hand
$83.7M
$291.6M
Total DebtLower is stronger
$333.9M
Stockholders' EquityBook value
$210.5M
$1.6B
Total Assets
$697.9M
$2.1B
Debt / EquityLower = less leverage
1.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PAMT
PAMT
TLRY
TLRY
Q4 25
$83.7M
$291.6M
Q3 25
$115.6M
$264.8M
Q2 25
$117.3M
$256.4M
Q1 25
$102.7M
Q4 24
$110.7M
$252.2M
Q3 24
$92.3M
$280.1M
Q2 24
$114.0M
$260.5M
Q1 24
$125.8M
$225.9M
Total Debt
PAMT
PAMT
TLRY
TLRY
Q4 25
$333.9M
Q3 25
Q2 25
Q1 25
Q4 24
$325.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PAMT
PAMT
TLRY
TLRY
Q4 25
$210.5M
$1.6B
Q3 25
$239.5M
$1.5B
Q2 25
$244.9M
$1.5B
Q1 25
$269.6M
$2.7B
Q4 24
$277.5M
$3.5B
Q3 24
$308.9M
$3.5B
Q2 24
$306.7M
$3.4B
Q1 24
$314.6M
$3.4B
Total Assets
PAMT
PAMT
TLRY
TLRY
Q4 25
$697.9M
$2.1B
Q3 25
$715.2M
$2.1B
Q2 25
$707.9M
$2.1B
Q1 25
$712.6M
Q4 24
$741.7M
$4.2B
Q3 24
$756.7M
$4.3B
Q2 24
$733.5M
$4.2B
Q1 24
$746.4M
$4.2B
Debt / Equity
PAMT
PAMT
TLRY
TLRY
Q4 25
1.59×
Q3 25
Q2 25
Q1 25
Q4 24
1.17×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PAMT
PAMT
TLRY
TLRY
Operating Cash FlowLast quarter
$-5.8M
$-8.5M
Free Cash FlowOCF − Capex
$-25.0M
FCF MarginFCF / Revenue
-17.7%
Capex IntensityCapex / Revenue
13.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PAMT
PAMT
TLRY
TLRY
Q4 25
$-5.8M
$-8.5M
Q3 25
$5.9M
$-1.3M
Q2 25
$12.2M
$-12.8M
Q1 25
$5.0M
$-5.8M
Q4 24
$15.2M
$-40.7M
Q3 24
$15.5M
$-35.3M
Q2 24
$18.7M
$30.7M
Q1 24
$9.6M
$-15.4M
Free Cash Flow
PAMT
PAMT
TLRY
TLRY
Q4 25
$-25.0M
Q3 25
$2.5M
Q2 25
$5.9M
$-19.1M
Q1 25
$-6.8M
$-20.2M
Q4 24
$-39.9M
$-46.2M
Q3 24
$-33.6M
$-42.0M
Q2 24
$4.1M
$21.0M
Q1 24
$-12.2M
$-24.9M
FCF Margin
PAMT
PAMT
TLRY
TLRY
Q4 25
-17.7%
Q3 25
1.7%
Q2 25
3.9%
-8.5%
Q1 25
-4.4%
-10.9%
Q4 24
-24.0%
-21.9%
Q3 24
-18.4%
-21.0%
Q2 24
2.2%
9.1%
Q1 24
-6.7%
-13.2%
Capex Intensity
PAMT
PAMT
TLRY
TLRY
Q4 25
13.6%
Q3 25
2.3%
Q2 25
4.2%
2.8%
Q1 25
7.6%
7.8%
Q4 24
33.1%
2.6%
Q3 24
26.9%
3.4%
Q2 24
8.0%
4.2%
Q1 24
12.0%
5.1%
Cash Conversion
PAMT
PAMT
TLRY
TLRY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
6.44×
Q2 24
Q1 24
34.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PAMT
PAMT

Freight Transportation Service$123.1M87%
Fuel Surcharge$18.2M13%

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

Related Comparisons